Giving patients oral antibiotics after aseptic joint revision surgery may actually backfire. Multiple studies show prophylactic antibiotics don't reduce periprosthetic joint infections (PJI) after revision hip or knee arthroplasty — and in some cases, they're linked to higher infection and wound complication rates. Experts say routine antibiotic prophylaxis in this setting lacks clear evidence and may carry real risks.
A growing body of evidence is challenging the routine use of prophylactic oral antibiotics after aseptic joint revision surgery. Across three studies presented at the Joint European Bone & Joint Infection Society-Musculoskeletal Infection Society Conference, researchers found that extended oral antibiotic prophylaxis did not reduce periprosthetic joint infection (PJI) rates after revision hip or knee arthroplasty — and in some cases, outcomes were worse.
In the most striking finding, patients who received prophylactic oral antibiotics after aseptic revision total hip arthroplasty (THA) had higher rates of PJI, superficial infection, and wound complications compared to those who didn't. Similarly, extended oral antibiotics showed no benefit in reducing PJI after aseptic revision total knee arthroplasty (TKA) out to 5 years, or after two-stage TKA reimplantation for existing PJI.
By the Numbers
Why it matters: Antibiotic overuse in this setting isn't just ineffective — it may actively increase infection risk and carries real adverse effects, including GI complications and kidney injury. Surgeons are being urged to move away from reflexive antibiotic prescribing and instead focus on identifying why a patient may be at higher risk in the first place.
